Lu-PSMA for Oligometastatic Prostate Cancer Treated With STereotactic Ablative Radiotherapy

Clinical trial NCT05560659 · RECRUITING

Trial details

NCT number: NCT05560659
Sponsor: Peter MacCallum Cancer Centre, Australia
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Oligometastatic Prostate Cancer

Start date: 2023-12-14
Primary completion: 2026-05-01
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.